drugset / Trial / NCT00832481
Comparison of the Effects of Repaglinide and Metformin on Glucose Excursions
RandomizedParallel-groupOpen-label
Summary
This is a 17 week, randomized, single center, open-label, parallel-group study to compare glucose excursions and other efficacy and safety parameters of repaglinide thrice daily or metformin thrice daily in newly diagnosed type 2 diabetes subjects in China.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-10
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metformin | Small molecule | 0.5 g | — |
| Comparator | Repaglinide | Small molecule | 0.5 mg | — |
| Comparator | Repaglinide | Small molecule | 1 mg | — |
| Comparator | Repaglinide | Small molecule | 2 mg | — |